17.84
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
6.26%
121.98
|
114.80 | 117.55 | 119.84 | 107.19 |
Cost Of Revenue |
1.96%
54.76
|
53.70 | 54.22 | 60.18 | 49.74 |
Gross Profit |
10.03%
67.23
|
61.10 | 63.33 | 59.66 | 57.45 |
|
6.82%
24.43
|
26.22 | 25.01 | 20.02 | 18.25 |
Benefits Costs and Expenses |
0.66%
81.89
|
81.35 | 82.84 | 83.09 | 71.34 |
Costs And Expenses |
0.66%
81.89
|
81.35 | 82.84 | 83.09 | 71.34 |
Depreciation and Amortization |
4.52%
2.058
|
1.969 | 1.944 | 1.94 | 2.047 |
Operating Income/Loss |
22.70%
42.80
|
34.88 | 38.32 | 39.64 | 39.20 |
Nonoperating Income/Loss |
88.75%
-2.701
|
-1.431 | -3.61 | -2.889 | -3.35 |
Income/Loss From Continuing Operations Before Tax |
19.87%
40.10
|
33.45 | 34.71 | 36.75 | 35.85 |
Income Tax Expense/Benefit, Deferred |
52.70%
1.62
|
3.425 | - | - | - |
Income Tax Expense/Benefit |
10.20%
5.878
|
6.546 | -77.18 | 0.84 | 3.789 |
Income/Loss From Continuing Operations After Tax |
27.19%
34.22
|
26.90 | 111.90 | 35.91 | 32.06 |
|
27.19%
34.22
|
26.90 | 111.90 | 35.91 | 32.06 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.56%
241.49
|
237.78 | 1.1247 | 234.57 | 232.42 |
Diluted Average Shares |
1.61%
248.61
|
244.68 | 1.5703 | 244.80 | 242.17 |
Basic Earnings Per Share |
27.27%
0.14
|
0.11 | 0.48 | 0.15 | 0.14 |
Diluted Earnings Per Share |
27.27%
0.14
|
0.11 | 0.46 | 0.15 | 0.13 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):